Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set
暂无分享,去创建一个
A. Bartley | M. Patnaik | M. Litzow | R. Go | G. Goyal | A. Al-Kali | M. Litzow | R. Go | M. Patnaik | G. Goyal
[1] R. Shi,et al. Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database. , 2016, Anticancer research.
[2] R. Shi,et al. Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality. , 2016, Anticancer research.
[3] Traci M. Blonquist,et al. Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis , 2015, Leukemia & lymphoma.
[4] A. Shinagare,et al. MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. , 2012, AJR. American journal of roentgenology.
[5] S. Devesa,et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. , 2012, Blood.
[6] M. Tallman,et al. How I treat extramedullary acute myeloid leukemia. , 2011, Blood.
[7] S. Pileri,et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients , 2007, Leukemia.
[8] S. Paydaş,et al. Granulocytic sarcoma: 32 cases and review of the literature , 2006, Leukemia & lymphoma.
[9] D. Selby,et al. Isolated Chloroma: The Effect of Early Antileukemic Therapy , 1995, Annals of Internal Medicine.
[10] J. Manning,et al. Granulocytic sarcoma in nonleukemic patients , 1986, Cancer.
[11] J. Bennett,et al. Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases , 1981, Cancer.